An open-label study to evaluate the safety profile of the new 500mg film-coated tablet formulation of boosted saquinavir (Invirase 500mg) in HIV-1 infected patients.

Trial Profile

An open-label study to evaluate the safety profile of the new 500mg film-coated tablet formulation of boosted saquinavir (Invirase 500mg) in HIV-1 infected patients.

Completed
Phase of Trial: Phase IV

Latest Information Update: 02 Jun 2011

At a glance

  • Drugs Ritonavir; Saquinavir
  • Indications HIV-1 infections
  • Focus Adverse reactions
  • Acronyms ESPrES-500
  • Sponsors Roche
  • Most Recent Events

    • 16 Feb 2008 Status changed from in progress to completed.
    • 09 Jun 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top